Oral tinidazole

DRUG2 trials

Sponsors

Kaiser Permanente, University of Toronto

Conditions

Foreskin HIV SusceptibilityRecurrent Bacterial Vaginosis

Phase 2

A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis

WithdrawnNCT00324142

Kaiser PermanenteRecurrent Bacterial Vaginosis

Updated: 2012-08-02

Unknown Phase

Effect of Antibiotics on Penile Microbiome and HIV Susceptibility Study in Ugandan Men

University of TorontoForeskin HIV Susceptibility

Start: 2017-12-07End: 2019-12-07Target: 125Updated: 2018-01-26

Related Papers

Protocol for a randomized clinical trial exploring the effect of antimicrobial agents on the penile microbiota, immunology and HIV susceptibility of Ugandan men

Trials2019-07-1911 citations